Wave Life Sciences (WVE) Research & Development (2014 - 2026)
Wave Life Sciences (WVE) posted Research & Development of $47.4 million for Q1 2026, down 10.18% on a QoQ basis from $52.8 million in Q4 2025, and up 16.78% year-over-year from $40.6 million in Q1 2025.
Wave Life Sciences (WVE) Research & Development (2014 - 2026) Analysis & Trends
Wave Life Sciences' Research & Development history runs 13 years deep, the most recent figure standing at $47.4 million for Q1 2026.
- Quarterly Research & Development rose 16.78% year-over-year to $47.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $189.6 million (up 13.63% YoY) and the FY2025 annual result came in at $182.8 million, up 14.46% from the prior year.
- Research & Development was $47.4 million for Q1 2026 at Wave Life Sciences, down from $52.8 million in the prior quarter.
- Across five years, Research & Development topped out at $52.8 million in Q4 2025 and bottomed at $27.5 million in Q1 2022.
- A 5-year average of $37.4 million and a median of $34.1 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development slipped 17.74% — and 2024, when it surged 31.02%.
- Wave Life Sciences' Research & Development stood at $31.1 million in 2022, then advanced by 9.64% to $34.1 million in 2023, then jumped by 31.02% to $44.6 million in 2024, then grew by 18.3% to $52.8 million in 2025, then decreased by 10.18% to $47.4 million in 2026.
- Business Quant data shows WVE's Research & Development at $47.4 million in Q1 2026, $52.8 million in Q4 2025, and $45.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 47.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.44 Mn |
| Dec 31, 2025 | 52.81 Mn |
| Sep 30, 2025 | 45.87 Mn |
| Jun 30, 2025 | 43.47 Mn |
| Mar 31, 2025 | 40.62 Mn |
| Dec 31, 2024 | 44.65 Mn |
| Sep 30, 2024 | 41.20 Mn |
| Jun 30, 2024 | 40.39 Mn |
| Mar 31, 2024 | 33.45 Mn |
| Dec 31, 2023 | 34.07 Mn |
| Sep 30, 2023 | 31.64 Mn |
| Jun 30, 2023 | 33.31 Mn |
| Mar 31, 2023 | 30.98 Mn |
| Dec 31, 2022 | 31.08 Mn |
| Sep 30, 2022 | 27.58 Mn |
| Jun 30, 2022 | 29.73 Mn |
| Mar 31, 2022 | 27.47 Mn |
| Dec 31, 2021 | 25.76 Mn |
| Sep 30, 2021 | 31.09 Mn |
| Jun 30, 2021 | 31.64 Mn |